Avermectin A1a

Avermectin A1a is a lipid of Polyketides (PK) class. Avermectin a1a is associated with abnormalities such as Ataxia with vitamin E deficiency, Strongyloidiasis, Congenital Transposition, Gigantism and Onchocerciasis. The involved functions are known as DNA Binding, Anabolism, Insertion Mutation, Process and physiological aspects. Avermectin a1a often locates in Chromosomes, Membrane, Clone, soluble and Tissue membrane. The associated genes with Avermectin A1a are Polypeptides, oxytocin, 1-desamino-(O-Et-Tyr)(2)-, Gene Feature, Genome and Gene Clusters. The related lipids are Propionate. The related experimental models are Mouse Model.

Cross Reference

Introduction

To understand associated biological information of Avermectin A1a, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Avermectin A1a?

Avermectin A1a is suspected in Ataxia with vitamin E deficiency, Gigantism, Strongyloidiasis, Congenital Transposition, Onchocerciasis, Tropical Disease and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Avermectin A1a

MeSH term MeSH ID Detail
Ostertagiasis D010029 2 associated lipids
Strongylida Infections D017206 5 associated lipids
Trichostrongylosis D014253 5 associated lipids
Lice Infestations D010373 9 associated lipids
Ectoparasitic Infestations D004478 2 associated lipids
Tuberculosis, Multidrug-Resistant D018088 6 associated lipids
Parasitic Diseases, Animal D010273 1 associated lipids
Scabies D012532 2 associated lipids
Larva Migrans D007815 1 associated lipids
Per page 10 20 | Total 19

PubChem Associated disorders and diseases

What pathways are associated with Avermectin A1a

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Avermectin A1a?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Avermectin A1a?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Avermectin A1a?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Avermectin A1a?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Avermectin A1a?

Mouse Model

Mouse Model are used in the study 'Anticonvulsant and adverse effects of avermectin analogs in mice are mediated through the gamma-aminobutyric acid(A) receptor.' (Dawson GR et al., 2000).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Avermectin A1a

Download all related citations
Per page 10 20 50 100 | Total 477
Authors Title Published Journal PubMed Link
Liu W et al. Increasing Avermectin Production in Streptomyces avermitilis by Manipulating the Expression of a Novel TetR-Family Regulator and Its Target Gene Product. 2015 Appl. Environ. Microbiol. pmid:26002902
Hwang YS et al. Cloning and analysis of a DNA fragment stimulating avermectin production in various Streptomyces avermitilis strains. 2003 Appl. Environ. Microbiol. pmid:12571055
Gao H et al. Assessing the potential of an induced-mutation strategy for avermectin overproducers. 2010 Appl. Environ. Microbiol. pmid:20453119
Trefzer A et al. Biocatalytic conversion of avermectin to 4''-oxo-avermectin: improvement of cytochrome p450 monooxygenase specificity by directed evolution. 2007 Appl. Environ. Microbiol. pmid:17483257
Jungmann V et al. Biocatalytic conversion of avermectin to 4"-oxo-avermectin: characterization of biocatalytically active bacterial strains and of cytochrome p450 monooxygenase enzymes and their genes. 2005 Appl. Environ. Microbiol. pmid:16269732
Molnár I et al. Biocatalytic conversion of avermectin to 4"-oxo-avermectin: heterologous expression of the ema1 cytochrome P450 monooxygenase. 2005 Appl. Environ. Microbiol. pmid:16269733
Kitani S et al. Characterization of a regulatory gene, aveR, for the biosynthesis of avermectin in Streptomyces avermitilis. 2009 Appl. Microbiol. Biotechnol. pmid:19148632
Zhang X et al. Construction of ivermectin producer by domain swaps of avermectin polyketide synthase in Streptomyces avermitilis. 2006 Appl. Microbiol. Biotechnol. pmid:16708195
Chen L et al. Characterization of a negative regulator AveI for avermectin biosynthesis in Streptomyces avermitilis NRRL8165. 2008 Appl. Microbiol. Biotechnol. pmid:18560830
Thuan NH et al. Recent advances in biochemistry and biotechnological synthesis of avermectins and their derivatives. 2014 Appl. Microbiol. Biotechnol. pmid:25104027